Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UKNOWN |
UNII: | 8375F9S90C |
InChI Key | DENYZIUJOTUUNY-MRXNPFEDSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C16H15FN4O |
Molecular Weight | 298.32 |
AlogP | 2.08 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 0.0 |
Polar Surface Area | 60.49 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 22.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Transferase
|
0-13 | 1 | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 51 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | 19400 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 23900 | - | - | - | |
Transporter
Primary active transporter
ATP-binding cassette
ABCG subfamily
|
- | - | - | - | 43 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4112930 |
DrugBank | DB14769 |
FDA SRS | 8375F9S90C |
PDB | DS9 |
SureChEMBL | SCHEMBL15084918 |
ZINC | ZINC000150196116 |